Source: BioPortfolio

Agile Sciences: Agile SciencesBreaking the Cycle of Antibiotic Resistance

The alarming and growing cases of antibiotic resistant bacteria and the diminishing number of effective antibiotics to fight infections is a welldocumented global health concern and also a potential national security issue. The Worl...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Malcolm Thomas's photo - President & CEO of Agile Sciences

President & CEO

Malcolm Thomas

CEO Approval Rating

90/100

Read more